< Back to research NRDC v. Andrew Wheeler et al Reference : 1:17-CV-02034-TSC Complaint date : October 3, 2017 Status : Provisional judgment Place of jurisdiction : United States, Washignton DC Plaintiffs types : Environmental NGOs Plaintiffs names : Natural Resources Defense Council Defendants : EPA, Andrew Wheeler Lawyers : Jolie D. McLaughlin, Rebecca J. Riley, Daniel L. Raichel, Lucas J. Rhoads Case nature : Administrative Specificities : Stipulated Settlement Agreement Products : Imidacloprid, Dinotefuran, Acetamiprid, Neonicotinoid, Insecticide Requests : NRDC ask for EPA to take into account the effects of dangerous active ingredients on 95 products regarding the Endangered Species Act Name of the Court : United States District Court for the District of Columbia of Washignton DC, United States Jurisdiction level : Court Decision date : January 15, 2021 Decision nature : Partially Positive Decision content : NRDC and EPA reached an agreement that requires EPA to begin evaluating the impacts of imidacloprid on endangered and threatened bees, butterflies, birds and other wildlife as required by the Endangered Species Act (ESA). Legal basis : National law Court Ruling : Link to the ruling Summary : Plaintiff files an action against EPA, alleging that it violated the Endangered Species Act (ESA), by failing to consult on the effects of 95 pesticide products registrations containing neonicotinoids: acetamiprid, dinotefuran, or imidacloprid, on Oct. 3, 2017. On Feb. 8, 2018, Parties entered into a Stipulation of Partial Dismissal of any and all claims related to 36 pesticide products. On January 15, 2021, Parties agreed to a partial settlement agreement which requires EPA to evaluate the impacts of imidacloprid and to meet to resolve the remaining issue on acetamiprid and dinotefuran. Scientific references : No scientifice reference for this case. Related links : "Exhibit A [Proposed] Stipulated Partial Settlement Agreement" NRDC Partial Settlement Agreement on Neonicotinoid Pesticide Imidacloprid